GSK Consumer Health is recalling approximately 433,600 bottles of Excedrin products as some of the bottles containing the over-the-counter drug may have a hole in the bottom.
The company has recalled the bottles as children could access and consume the contents in the bottles, which posed a risk of poisoning.
Go deeper with GlobalData
The bottles that are subject to recall contain Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin Pm Headache Caplets and Excedrin Tension Headache Caplets.
GSK Consumer Health said that 50, 80, 100, 125, 200, 250 and 300-count bottles are being recalled.
The bottles that are part of the recall were sold at pharmacies, department stores, grocery stores, and hypermarkets across the US, as well as online from March 2018 through September 2020.
The company said that the products inside the bottle contain substances such as aspirin and acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
However, the company said that the plastic bottles come with a child-resistant closure.
GSK said that so far it has not received any complaints or safety concerns to-date on this potential problem.
It has urged consumers to immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine the presence of a hole.
If consumers spot a hole in the bottle, they have been advised to contact GSK Consumer Relations for information on how to return and receive a full refund via a prepaid shipping label.
The company said that it was working with the bottle manufacturer to fix the problem as quickly as possible.
However, GSK added that bottles without holes could be retained and used as directed.
